BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 14512604)

  • 21. Toxicology. Panel urges further study of biotech corn.
    Kaiser J
    Science; 2000 Dec; 290(5498):1867. PubMed ID: 11187032
    [No Abstract]   [Full Text] [Related]  

  • 22. The Bush administration deals a blow to biotechnology--and itself.
    Miller HI
    Nat Biotechnol; 2001 Sep; 19(9):807-8. PubMed ID: 11533629
    [No Abstract]   [Full Text] [Related]  

  • 23. A framework for designing transgenic crops--science, safety and citizen's concerns.
    König A
    Nat Biotechnol; 2003 Nov; 21(11):1274-9. PubMed ID: 14595351
    [No Abstract]   [Full Text] [Related]  

  • 24. GM grass eludes outmoded USDA oversight.
    Waltz E
    Nat Biotechnol; 2011 Sep; 29(9):772-3. PubMed ID: 21904303
    [No Abstract]   [Full Text] [Related]  

  • 25. Drugs in crops (continued).
    Phillips GC
    Nat Biotechnol; 2004 Jun; 22(6):655-6. PubMed ID: 15175676
    [No Abstract]   [Full Text] [Related]  

  • 26. GM crops in the cross hairs.
    Ferber D
    Science; 1999 Nov; 286(5445):1662-6. PubMed ID: 10610557
    [No Abstract]   [Full Text] [Related]  

  • 27. Agriculture. Biotech crops good for farmers and environment, Academy finds.
    Stokstad E
    Science; 2010 Apr; 328(5976):295. PubMed ID: 20395485
    [No Abstract]   [Full Text] [Related]  

  • 28. US regulatory system for genetically modified [genetically modified organism (GMO), rDNA or transgenic] crop cultivars.
    McHughen A; Smyth S
    Plant Biotechnol J; 2008 Jan; 6(1):2-12. PubMed ID: 17956539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biotech companies must get back to basics to weigh up risks.
    Ewbank J
    Nature; 1999 Sep; 401(6750):207. PubMed ID: 10499565
    [No Abstract]   [Full Text] [Related]  

  • 30. GM crops and the pesticide paradigm.
    Welsh R; Hubbell B; Ervin DE; Jahn M
    Nat Biotechnol; 2002 Jun; 20(6):548-9. PubMed ID: 12042850
    [No Abstract]   [Full Text] [Related]  

  • 31. US sends mixed message in GM debate...as questions emerge over cost-effectiveness.
    Reichhardt T
    Nature; 1999 Jul; 400(6742):298. PubMed ID: 10432097
    [No Abstract]   [Full Text] [Related]  

  • 32. Value judgments and risk comparisons. The case of genetically engineered crops.
    Thompson PB
    Plant Physiol; 2003 May; 132(1):10-6. PubMed ID: 12746505
    [No Abstract]   [Full Text] [Related]  

  • 33. Policy: Reboot the debate on genetic engineering.
    Kuzma J
    Nature; 2016 Mar; 531(7593):165-7. PubMed ID: 26961641
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharming in crop commodities.
    Stewart CN
    Nat Biotechnol; 2008 Nov; 26(11):1222-3. PubMed ID: 18997756
    [No Abstract]   [Full Text] [Related]  

  • 35. Regulatory regimes for transgenic crops.
    Wilson A; Latham J; Steinbrecher R
    Nat Biotechnol; 2005 Jul; 23(7):785; author reply 787-9. PubMed ID: 16003352
    [No Abstract]   [Full Text] [Related]  

  • 36. Liabilities and economics of transgenic crops.
    Smyth S; Khachatourians GG; Phillips PW
    Nat Biotechnol; 2002 Jun; 20(6):537-41. PubMed ID: 12042844
    [No Abstract]   [Full Text] [Related]  

  • 37. Trace and traceability--a call for regulatory harmony.
    Ramessar K; Capell T; Twyman RM; Quemada H; Christou P
    Nat Biotechnol; 2008 Sep; 26(9):975-8. PubMed ID: 18779799
    [No Abstract]   [Full Text] [Related]  

  • 38. Are Bt crops safe?
    Mendelsohn M; Kough J; Vaituzis Z; Matthews K
    Nat Biotechnol; 2003 Sep; 21(9):1003-9. PubMed ID: 12949561
    [No Abstract]   [Full Text] [Related]  

  • 39. War on weeds loses ground.
    Thompson H
    Nature; 2012 May; 485(7399):430. PubMed ID: 22622548
    [No Abstract]   [Full Text] [Related]  

  • 40. CGIAR under pressure to support seed treaty.
    Meldolesi A
    Nat Biotechnol; 2002 Feb; 20(2):103-5. PubMed ID: 11821839
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.